410 related articles for article (PubMed ID: 18796646)
1. Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis.
Fermas S; Gonnet F; Sutton A; Charnaux N; Mulloy B; Du Y; Baleux F; Daniel R
Glycobiology; 2008 Dec; 18(12):1054-64. PubMed ID: 18796646
[TBL] [Abstract][Full Text] [Related]
2. Desorption electrospray ionization mass spectrometry of glycosaminoglycans and their protein noncovalent complex.
Przybylski C; Gonnet F; Hersant Y; Bonnaffé D; Lortat-Jacob H; Daniel R
Anal Chem; 2010 Nov; 82(22):9225-33. PubMed ID: 21028826
[TBL] [Abstract][Full Text] [Related]
3. Frontal analysis capillary electrophoresis hyphenated to electrospray ionization mass spectrometry for the characterization of the antithrombin/heparin pentasaccharide complex.
Fermas S; Gonnet F; Varenne A; Gareil P; Daniel R
Anal Chem; 2007 Jul; 79(13):4987-93. PubMed ID: 17536781
[TBL] [Abstract][Full Text] [Related]
4. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.
Moy FJ; Safran M; Seddon AP; Kitchen D; Böhlen P; Aviezer D; Yayon A; Powers R
Biochemistry; 1997 Apr; 36(16):4782-91. PubMed ID: 9125499
[TBL] [Abstract][Full Text] [Related]
5. Solution studies of recombinant human stromal-cell-derived factor-1.
Holmes WD; Consler TG; Dallas WS; Rocque WJ; Willard DH
Protein Expr Purif; 2001 Apr; 21(3):367-77. PubMed ID: 11281710
[TBL] [Abstract][Full Text] [Related]
6. Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb.
Luo Y; Ye S; Kan M; McKeehan WL
J Cell Biochem; 2006 Apr; 97(6):1241-58. PubMed ID: 16315317
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycan disaccharide alters the dimer dissociation constant of the chemokine MIP-1 beta.
McCornack MA; Boren DM; LiWang PJ
Biochemistry; 2004 Aug; 43(31):10090-101. PubMed ID: 15287737
[TBL] [Abstract][Full Text] [Related]
8. Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue.
Canales A; Lozano R; López-Méndez B; Angulo J; Ojeda R; Nieto PM; Martín-Lomas M; Giménez-Gallego G; Jiménez-Barbero J
FEBS J; 2006 Oct; 273(20):4716-27. PubMed ID: 16995857
[TBL] [Abstract][Full Text] [Related]
9. Structures of heparin-derived tetrasaccharide bound to cobra cardiotoxins: heparin binding at a single protein site with diverse side chain interactions.
Tjong SC; Chen TS; Huang WN; Wu WG
Biochemistry; 2007 Sep; 46(35):9941-52. PubMed ID: 17685633
[TBL] [Abstract][Full Text] [Related]
10. Analysis of heparin oligosaccharides by capillary electrophoresis-negative-ion electrospray ionization mass spectrometry.
Lin L; Liu X; Zhang F; Chi L; Amster IJ; Leach FE; Xia Q; Linhardt RJ
Anal Bioanal Chem; 2017 Jan; 409(2):411-420. PubMed ID: 27325464
[TBL] [Abstract][Full Text] [Related]
11. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites.
Goger B; Halden Y; Rek A; Mösl R; Pye D; Gallagher J; Kungl AJ
Biochemistry; 2002 Feb; 41(5):1640-6. PubMed ID: 11814358
[TBL] [Abstract][Full Text] [Related]
12. Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus.
Ziarek JJ; Veldkamp CT; Zhang F; Murray NJ; Kartz GA; Liang X; Su J; Baker JE; Linhardt RJ; Volkman BF
J Biol Chem; 2013 Jan; 288(1):737-46. PubMed ID: 23148226
[TBL] [Abstract][Full Text] [Related]
13. Capillary Electrophoresis-Mass Spectrometry for the Analysis of Heparin Oligosaccharides and Low Molecular Weight Heparin.
Sun X; Lin L; Liu X; Zhang F; Chi L; Xia Q; Linhardt RJ
Anal Chem; 2016 Feb; 88(3):1937-43. PubMed ID: 26714061
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of the fucoidan sulfated L-fucose isomers constituents by CE-ESIMS and molecular modeling.
Tissot B; Salpin JY; Martinez M; Gaigeot MP; Daniel R
Carbohydr Res; 2006 Apr; 341(5):598-609. PubMed ID: 16413001
[TBL] [Abstract][Full Text] [Related]
15. Lysine and arginine side chains in glycosaminoglycan-protein complexes investigated by NMR, cross-linking, and mass spectrometry: a case study of the factor H-heparin interaction.
Blaum BS; Deakin JA; Johansson CM; Herbert AP; Barlow PN; Lyon M; Uhrín D
J Am Chem Soc; 2010 May; 132(18):6374-81. PubMed ID: 20394361
[TBL] [Abstract][Full Text] [Related]
16. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
[TBL] [Abstract][Full Text] [Related]
17. Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions.
Joseph PR; Mosier PD; Desai UR; Rajarathnam K
Biochem J; 2015 Nov; 472(1):121-33. PubMed ID: 26371375
[TBL] [Abstract][Full Text] [Related]
18. Interaction of human β-defensin 2 (HBD2) with glycosaminoglycans.
Seo ES; Blaum BS; Vargues T; De Cecco M; Deakin JA; Lyon M; Barran PE; Campopiano DJ; Uhrín D
Biochemistry; 2010 Dec; 49(49):10486-95. PubMed ID: 21062008
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV.
Sadir R; Imberty A; Baleux F; Lortat-Jacob H
J Biol Chem; 2004 Oct; 279(42):43854-60. PubMed ID: 15292258
[TBL] [Abstract][Full Text] [Related]
20. Glycosaminoglycans as naturally occurring combinatorial libraries: developing a mass spectrometry-based strategy for characterization of anti-thrombin interaction with low molecular weight heparin and heparin oligomers.
Abzalimov RR; Dubin PL; Kaltashov IA
Anal Chem; 2007 Aug; 79(16):6055-63. PubMed ID: 17658885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
